glp 1 meds and alzheimer's Details of failed studies cast pall on Novo Nordisk's GLP-1 as treatment GLP-1 and Alzheimer's Disease: Research

tudes scientifiques

Calcium and vitamin D intake, along with regular exercise, can help mitigate this risk

Healthy user bias is very difficult to scrub out of observational studies, which compare people as they are treated in real life rather than assigning the drug at random

Such molecules may be appropriate for use at the first indication of mild cognitive impairment, and perhaps prophylactically in those individuals who are most likely to develop dementia due to genetic, health, behavioral and life-style predisposing factors

Raised intracranial pressure has a direct effect on the vomiting centre leading to vomiting